Neurontin
Neurontin is a drug that is given to patients after they have suffered through a case of shingles. It is a drug that is taken orally and is approved by the Food and Drug Administration to treat postherpetic neuralagia (PHN), which is to say pain that takes place in the nerves of sufferers. In brief, PHN is the pain that sets in approximately one to three months after shingles has healed up. This pain can range from mild to very serious and studies have shown that neurontin is very effective in managing this particular kind of pain.
Besides the pain after shingles, neurontin is often prescribed to help both children over the age of three and adults who experience partial seizures. Neurontin varies in how it helps patients who take it. Some people notice an improvement in their symptoms as early as a week or two while for others it takes even longer. This is unique to the individual.
Neurontin is a very convenient drug because it can be made available to a patient in one of three forms- liquid, capsules or scored tablets. It is generally up to the doctor to decided what form of the medicine a patient requires and also what kind of dosage a patient needs in order to decrease their level of pain.
Neurontin is made by the pharmaceutical company Pfizer Inc. that has been helping people fight pain for more than 150 years. This particular drug has been actively available for the past ten years and it has benefited in excess of millions of individuals. Before it was prescribed for postherpetic neuralgia, neurontin was used to treat those who suffered from epilepsy. It has proven successful at relieving the painful symptoms of both diseases.
The main ingredient in neurontin is gabapentin. For those who think they may be allergic to gabapentin it is important to make their doctor aware of this before the drug is prescribed to them. Also, it may be a good idea to ask your doctor about neurontin side effects that may occur.
Disclaimer: Cliff Schaffer does not personally endorse or support any of the comments made within the writings of this article. |
